Showing results (411-420 of 439) with videos related to

Sort By:
Pageof 44
Plos Genetics|December 4, 2009
Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumorAnthony R Dallosso, Anne L Hancock, Marianna Szemes, et al.
Neuro-Oncology|February 13, 2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium reportIan F Pollack, Regina I Jakacki, Susan M Blaney, et al.
Seminars in Radiation Oncology|March 23, 2016
Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic RadiosurgerySusan M Hiniker, Leslie A Modlin, Clara Y Choi, et al.
Molecular Ecology Resources|March 25, 2011
Sperm whale population structure in the eastern and central North Pacific inferred by the use of single-nucleotide polymorphisms, microsatellites and mitochondrial DNASarah L Mesnick, Barbara L Taylor, Frederick I Archer, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.
Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.
JAMA Oncology|September 14, 2023
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled TrialMichael F Gensheimer, Harriet Gee, Hiroki Shirato, et al.
Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.
Pragmatic and Observational Research|July 12, 2022
Characterisation of the Australian Adult Population Living with Asthma: Severe - Exacerbation Frequency, Long-Term OCS Use and Adverse EffectsKerry L Hancock, Sinthia Bosnic-Anticevich, John D Blakey, et al.
ACS Chemical Biology|July 10, 2019
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone DemethylasesMartin Roatsch, Inga Hoffmann, Martine I Abboud, et al.
Pageof 44